Skip to main content
Discovering the causes of cancer and the means of prevention

Past Events

  • 2020 American Association for Cancer Research (AACR) Annual Meeting

    List of presentations given by DCEG staff at the virtual 2020 American Association for Cancer Research (AACR) Annual Meeting.

    June 22 – June 24, 2020
  • International Society for Radiation Epidemiology and Dosimetry, Inaugural Meeting

    Inaugural Meeting of the International Society for Radiation Epidemiology and Dosimetry will take place May 5-8, 2020, in Sitges, Spain. Investigators in the Radiation Epidemiology Branch

    May 5 – May 8, 2020
    Sitges, Spain
  • Miocrobiome - Drs. Shi and Gail, Part 3 of 3

    Biostatistics at the Frontier Seminar Series

    This seminar is Part 3 of 3 of the 2020 Biostatistics at the Frontier seminar series

    April 30, 2020 | 10:30 AM – 11:00 AM
    NCI Shady Grove TE 406 Rockville, Maryland
  • Bayes Regularization and Microbiome Multi-Omics: A Two-Tailed Narrative - Dr. Mallick

    Biostatistics Branch Seminar Series

    In this talk, I will present a statistical narrative of two seemingly different but equally exciting topics: Bayes regularization and microbiome multi-omics, drawing upon my PhD and postdoc experience of researching in two vastly different academic settings.

    April 21, 2020 | 9:00 AM – 10:00 AM
    NCI Shady Grove Webex only
  • Novel Epidemiological Risk Models, with Application to Screening - Dr. Cheung

    Biostatistics Branch Seminar Series

    My research interest focuses on the development of statistical methods for analyzing electronic health record data, using these methods to model the natural history of intervening stages in the carcinogenic process, and the development of evidence-based cancer screening guidelines. I will discuss some of the critical statistical challenges involved in analyzing such data, and why standard tools for absolute and relative risk estimation are biased. I will introduce new statistical models that can be used to produce unbiased estimates in cohort studies with multiple time point data and biospecimen collection. These models are used to develop new risk-based management guidelines for cervical cancer. I will also discuss risk models and benefit models for oral cancer and lung cancer screening.

    April 20, 2020 | 10:30 AM – 11:30 AM
  • Virtual Pooled Registry- Dr. Danping Liu, Part 2 of 3

    Biostatistics at the Frontier Seminar Series

    This seminar is a part 2 of 3 of the 2020 Biostatistics at the Frontier Seminar Series

    April 9, 2020 | 10:30 AM – 11:00 AM
    NCI Shady Grove TE 110 Rockville, Maryland
  • Feature Selection with Survival Outcome Data - Dr. Hong

    Biostatistics Branch Seminar Series

    Detecting biomarkers that are relevant to patients' survival outcome is crucial for precision medicine. Dimension reduction is key in the process. Although regularization methods have been used for dimension reduction, they cannot handle a large number of candidate biomarkers generated by modern bio-techniques. Variable screening, which has been widely used for handling exceedingly large numbers of variables, is however much underdeveloped for censored outcome data.

    April 1, 2020 | 10:30 AM – 11:30 AM
  • Methods for Population Health with Limited Data - Dr. Li

    Biostatistics Branch Seminar Series

    Data describing health outcomes of hidden populations and in low-resource areas are usually noisy and incomplete. In this talk, I will discuss two projects in such data-constrained settings.

    March 31, 2020 | 10:30 AM – 11:30 AM
  • NIH Human Subjects Research Protections Program – Updates for DCEG Studies - Drs. Savage and McMaster

    DCEG Seminar

    Drs. Savage and McMaster will provide an update on the central NIH IRB, Non Human Subject Research (NHSR), and NCI Ethical Review Panel review processes for DCEG studies. All are highly encouraged to attend to receive clarifications on these processes.

    March 25, 2020 | 11:00 AM – 12:00 PM
  • Estimating Somatic Variant Richness & Using the “Hidden” Genome to Improve Classification of Cancer Types - Dr. Chakraboty

    Biostatistics Branch Seminar Series

    It is increasingly common clinically for cancer specimens to be examined using techniques that identify somatic mutations. In principle these mutational profiles can be used to diagnose the tissue of origin, a critical task for the 3-5% of tumors that have an unknown primary site. Diagnosis of primary site is also critical for screening tests that employ circulating DNA.

    March 10, 2020 | 10:30 AM – 11:30 AM
    NCI Shady Grove 2W032/034 Rockville, Maryland